Fact CheckerSign in

NCT06291532Enrolling by invitation

Feasibility and Usability of a Virtual Reality System

Feasibility and Usability of a Virtual Reality System to Improve Standardized Rehabilitation in Patients With Moderate Intellectual Disability and Severe Autism Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 8 Oct 2026

Brief summary (registry, in English)

Intellectual disability (ID) and autism spectrum disorder (ASD) are often co-occurring neurodevelopmental disorders that require composite intervention. However, standardized rehabilitation programs presented several limitations due to behavioral problems and poor engagement in proposed activity. The Virtual Reality Rehabilitation System (VRRS) is a medical device is recognized as one of the most advanced systems to rehabilitate patients with motor, cognitive, linguistic and behavioral disorders. The use of VRRS offers the opportunity to adapting task parameters according to the patient's performance and the virtual system increases engagement and avoids boredom and frustration. the patients underwent a two months experimental intervention integrated into the regular activity of a semi-residential center for autistic adolescents and young adults.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
100 (estimated)
First submitted
9 Feb 2024
Start date
1 Apr 2023
Primary completion date
30 Sept 2025
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
Diseases
Autism
NCT number
NCT06291532

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 1 Apr 2023 to the primary completion date, 30 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • subjects without diagnosis of ASD and ID, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);

Age

  • age not between 6 and 40 years;

Other

  • cognitive level \>75 Intellectual Quotient
  • unsigned informed consent

Who the study is looking for

  • subjects diagnosed with ASD and ID, according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5);
  • age between 6 and 40 years;
  • cognitive level ≤75 Intellectual Quotient
  • signed informed consent

Age in the registry: 6 years to 40 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Centro Neurolesi Bonino Pulejo
Coordinator of this site? Confirm its status
MessinaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.